PDCD1 and neoplasm: Specifically, recent studies confirm that IRF4 upregulation following T cell activation impedes human CD8 T cell effector function, while promoting cell proliferation and PD-1 expression, contributing to an exhausted phenotype in tumor-infiltrating lymphocytes (TILs) rather than activation alone 45.